An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol

  1. Krolewiecki, A.
  2. Enbiale, W.
  3. Gandasegui, J.
  4. van Lieshout, L.
  5. Kepha, S.
  6. Messa Junior, A.
  7. Bengtson, M.
  8. Gelaye, W.
  9. Escola, V.
  10. Martinez-Valladares, M.
  11. Cambra-Pellejà, M.
  12. Algorta, J.
  13. Martí-Soler, H.
  14. Fleitas, P.
  15. Ballester, M.R.
  16. Doyle, S.R.
  17. Williams, N.A.
  18. Legarda, A.
  19. Mandomando, I.
  20. Mwandawiro, C.
  21. Muñoz, J.
Revue:
Gates Open Research

ISSN: 2572-4754

Année de publication: 2022

Volumen: 6

Type: Article

DOI: 10.12688/GATESOPENRES.13615.1 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus